At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

Blog

September 13, 2017 Hits and Misses from the Cough Conferences – Part 2: Summary from American Cough Conference
Here are the three hits and one miss from the American Cough Conference: Hit: Conference itself was GREAT While we sent one representative to the American Thoracic Society conference, there were three of us at the American Cough Conference due to its almost exclusive focus on chronic cough. The agenda was packed with presentations of high interest to our team (animal cough models, cough...
Read More
July 19, 2017 Hits and Misses from the Cough Conferences – Part 1: A Review of the Merck P2X3 Antagonist Data
Over the course of the last couple of months, the BELLUS Health team attended two important conferences: the American Thoracic Society (ATS) Conference and the American Cough Conference (ACC). While ATS is a very large and broad respiratory conference, ACC is a highly-specialized conference focused primarily on chronic cough. It was at ATS that Merck presented for the first time the latest...
Read More

Share this

Sign up for email alerts

Email Address *
 
Enter the code shown above.